Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rafael Melgares
Observed names:
Melgares R,
R MELGARES,
R Melgares,
R. MELGARES,
R. Melgares,
RAFAEL MELGARES,
Rafael Melgares,
show all 7
Institutions:
Hospital Clínico San Carlos,
Fundación Interhospitalaria para la Investigación Cardiovascular
Observed institutions:
Hospital Clínico San Carlos,
Fundación Interhospitalaria para la Investigación Cardiovascular,
Hospital Universitario Puerta de Hierro Majadahonda,
Hospital Universitario Virgen de las Nieves,
Vall d'Hebron Hospital Universitari,
Hospital Universitario de La Princesa
show all 6
OpenAlex ID:
A5043611553
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents
2015
·
Fernando Alfonso
, María Jose Pérez-Vizcayno
, et al.
·
Journal of the American College of Cardiology
·
325
A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal Stent–In-Stent Restenosis
2014
·
Fernando Alfonso
, Maria Jose Pérez-Vizcayno
, et al.
·
Journal of the American College of Cardiology
·
273
Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies
2010
·
H. Bueno
, A. Betriu
, et al.
·
European Heart Journal
·
185
PDF
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial
2018
·
Fernando Alfonso
, María José Pérez-Vizcayno
, et al.
·
JACC: Cardiovascular Interventions
·
119
PDF
Pronóstico y manejo del síndrome coronario agudo en España en 2012: estudio DIOCLES
2014
·
José A. Barrabés
, Alfredo Bardají
, et al.
·
Revista Española de Cardiología
·
110
Implantation of a Drug-Eluting Stent With a Different Drug (Switch Strategy) in Patients With Drug-Eluting Stent Restenosis
2012
·
Fernando Alfonso
, Maria J. Pérez-Vizcayno
, et al.
·
JACC: Cardiovascular Interventions
·
106
PDF
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
2017
·
Muthiah Vaduganathan
, Robert A. Harrington
, et al.
·
Journal of the American College of Cardiology
·
59
PDF
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type
2014
·
E. Camenzind
, E. Boersma
, et al.
·
European Heart Journal
·
49
Prognosis and Management of Acute Coronary Syndrome in Spain in 2012: The DIOCLES Study
2014
·
José A. Barrabés
, Alfredo Bardají
, et al.
·
Revista Española de Cardiología (English Edition)
·
45
Cavotricuspid Isthmus Catheter Ablation Without the Use of Fluoroscopy as a First-Line Treatment
2010
·
MIGUEL ÁLVAREZ
, LUÍS TERCEDOR
, et al.
·
Journal of Cardiovascular Electrophysiology
·
34
Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials
2016
·
Fernando Alfonso
, María José Pérez-Vizcayno
, et al.
·
Circulation Cardiovascular Interventions
·
27
PDF
Therapeutic implications of in-stent restenosis located at the stent edge. Insights from the restenosis intra-stent balloon angioplasty versus elective stenting (RIBS) randomized trial.
2004
·
F ALFONSO
, R MELGARES
, et al.
·
European Heart Journal
·
21
A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study)
2017
·
Arturo García-Touchard
, Javier Goicolea
, et al.
·
EuroIntervention
·
19
Resultados iniciales y seguimiento clínico a 6 meses tras el implante de un stent coronario recubierto de carburo de silicio
2001
·
Juan A. Fournier
, José Calabuig
, et al.
·
Revista Española de Cardiología
·
19
Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)
2017
·
Fernando Alfonso
, María José Pérez-Vizcayno
, et al.
·
The American Journal of Cardiology
·
14
Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome
2010
·
Irene Amorós
, Juan Jiménez-Jáimez
, et al.
·
Heart Rhythm
·
12
Low Clinical Penetrance in Causal Mutation Carriers for Cardiac Channelopathies
2012
·
Juan Jiménez-Jáimez
, Miguel Álvarez
, et al.
·
Revista Española de Cardiología (English Edition)
·
10
Uso amplio de stenting coronario directo. Estudio DISCO 2
2003
·
Luis Martínez Elbal
, Susana Mingo
, et al.
·
Revista Española de Cardiología
·
10
The value of exercise electrocardiography testing in the identification of coronary restenosis: a probability analysis
1995
·
José Azpitarte
, Luis Tercedor
, et al.
·
International Journal of Cardiology
·
10
Success determining factors in percutaneous transluminal balloon valvuloplasty of pulmonary valve stenosis
1991
·
R. MELGARES
, J. A. PRIETO
, et al.
·
European Heart Journal
·
9
Baja penetrancia clínica en sujetos portadores de mutación patogénica para las canalopatías cardiacas
2012
·
Juan Jiménez-Jáimez
, Miguel Álvarez
, et al.
·
Revista Española de Cardiología
·
7
Angiographic follow-up of cutting balloon vs conventional balloon angioplasty. Results of the CUBA Study
1998
·
C. Moris
, A Bethencourt
, et al.
·
Journal of the American College of Cardiology
·
6
PDF
Utilidad del examen angiográfico de la arteria mamaria interna izquierda en pacientes candidatos a cirugía de derivación coronaria
1997
·
Juan Emilio Alcalá
, Miguel Álvarez
, et al.
·
Revista Española de Cardiología
·
6
[Aortic stenosis with left ventricular systolic dysfunction: a severe disease but with good surgical prognosis].
1989
·
I Rodríguez Bailón
, J Azpitarte
, et al.
·
PubMed
·
6
Significant coronary restenosis limits the recovery of regional left myocardial dysfunction achieved after successful coronary angioplasty
1993
·
R. MELGARES
, J. A. PRIETO
, et al.
·
European Heart Journal
·
5
Show more works
View as search
Works count:
38
Citation count:
1,502
H-index:
14
I10-index:
19
Year
Topic
Type